コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 these genes exhibited altered expression in neurodegenerative and behavioral diseases and were assoc
9 uclear palsy (PSP) is a rare and progressive neurodegenerative condition characterised pathologically
10 hic lateral sclerosis (ALS) is a progressive neurodegenerative condition primarily involving the moto
11 re, we report an unusual autosomal recessive neurodegenerative condition, best classified as a compli
12 s of cerebellar grey matter atrophy in seven neurodegenerative conditions (Alzheimer's disease (AD),
13 esearch in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as m
14 be a therapeutic strategy in a wide range of neurodegenerative conditions and consider possible pathw
17 including Alzheimer's disease (AD) and other neurodegenerative conditions, are defined by a pathologi
20 potential disease mechanisms underlying the neurodegenerative consequences of CISD2 mutations and th
21 ewy bodies is the second most common form of neurodegenerative dementia, yet scarce evidence is avail
22 ce from AD and HD studies suggest that other neurodegenerative dementias would also benefit from imag
24 most common cause of inherited forms of the neurodegenerative disease amyotrophic lateral sclerosis
25 ational cohort comprising 3100 patients with neurodegenerative disease and 4351 healthy control subje
27 as the potential link between LSD1 and human neurodegenerative disease and find that loss of LSD1 ind
29 form efforts to better understand and manage neurodegenerative disease and other proteinopathies.
30 endrocytes and its potential impact in human neurodegenerative disease and related animal models.
31 principles established within other areas of neurodegenerative disease and the nuances of clinicopath
34 taxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease caused by CAG repeat expansion
36 Spinocerebellar ataxia type 5 (SCA5) is a neurodegenerative disease caused by mutations in the cyt
37 type 35 (SCA35) is a rare autosomal-dominant neurodegenerative disease caused by mutations in the TGM
38 ntington's disease is a dominantly inherited neurodegenerative disease caused by the expansion of a C
39 at tau-transgenic (tau-tg) mice that develop neurodegenerative disease characterized by deposition of
40 phic lateral sclerosis (ALS) is debilitating neurodegenerative disease characterized by motor neuron
41 ms of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by progressive a
45 c variants at the 7p21 locus and risk of the neurodegenerative disease frontotemporal lobar degenerat
47 elationship between repeated concussions and neurodegenerative disease has received significant atten
48 etch close to the C-terminus that triggers a neurodegenerative disease in humans when its length exce
51 ouse model of Batten disease, a prototypical neurodegenerative disease presenting with intralysosomal
52 multiple states of microglial activation in neurodegenerative disease settings, which might explain
53 inal muscular atrophy (SMA) is a progressive neurodegenerative disease that is the leading genetic ca
55 xpression in Friedreich's ataxia, a terminal neurodegenerative disease with no effective therapy.
56 Alzheimer's disease (AD) is a detrimental neurodegenerative disease with no effective treatments.
57 pinal muscular atrophy (SMA) is a hereditary neurodegenerative disease with severity ranging from pro
58 e Sclerosis (MS), a chronic inflammatory and neurodegenerative disease, although a mechanistic basis
59 lerosis (ALS) is a devastating and incurable neurodegenerative disease, characterised by progressive
60 ke that of other proteins that accumulate in neurodegenerative disease, however, the function of alph
61 Retinitis pigmentosa (RP) is an inherited neurodegenerative disease, in which the death of mutant
62 in tissues of the CNS and is associated with neurodegenerative disease, particularly Parkinson-like s
63 ophic lateral sclerosis (ALS), a progressive neurodegenerative disease, we measured electromyogram (E
64 ht on how oxidative stress can contribute to neurodegenerative disease, with unfolding, aggregation,
81 cribe a novel microglia type associated with neurodegenerative diseases (DAM) and identify markers, s
83 include fibrils associated with systemic and neurodegenerative diseases and cancer, functional amyloi
84 ings demonstrate genetic pleiotropy in these neurodegenerative diseases and indicate that sporadic FT
85 iseases such as lysosomal storage disorders, neurodegenerative diseases and metabolic pathologies, as
86 d could offer new therapeutic approaches for neurodegenerative diseases and other chronic disorders r
87 the implications for other R-loop-associated neurodegenerative diseases and point to future therapeut
92 rapeutic drug targets.SIGNIFICANCE STATEMENT Neurodegenerative diseases are diagnosed definitively on
94 y occurring post-translation modification in neurodegenerative diseases as well as other pathological
95 hat genetic variants associated with risk of neurodegenerative diseases beyond frontotemporal lobar d
96 ological oligomeric forms in different human neurodegenerative diseases by ELISA, immunohistochemistr
98 (TDP-43) misfolding is implicated in several neurodegenerative diseases characterized by aggregated p
99 hondrial quality control have been linked to neurodegenerative diseases due in part to the central ro
101 ical markers of oxidative stress, aging, and neurodegenerative diseases including Alzheimer's disease
102 tic applications using various specimens for neurodegenerative diseases including Alzheimer's disease
103 ociated protein tau is implicated in various neurodegenerative diseases including Alzheimer's disease
104 Astroglial pathology is seen in various neurodegenerative diseases including frontotemporal deme
105 and missense mutations in TFG cause several neurodegenerative diseases including hereditary motor an
106 minases have been shown to be hyperactive in neurodegenerative diseases including multiple sclerosis.
109 alpha-Synuclein (aSyn) is the main driver of neurodegenerative diseases known as "synucleinopathies,"
110 somal storage disorders (LSDs) and to common neurodegenerative diseases like Alzheimer's and Parkinso
111 nc and iron, and oxidative stress in several neurodegenerative diseases like Alzheimer's, Parkinson's
112 rly detection of the behavioural deficits of neurodegenerative diseases may help to describe the path
115 , specific contributions of BMAA toxicity to neurodegenerative diseases remain to be fully resolved.
117 /reperfusion injury, cataract formation, and neurodegenerative diseases such as Alzheimer's disease (
118 ght underlie the progression of pathology in neurodegenerative diseases such as Alzheimer's disease,
119 Prions are infectious agents that cause neurodegenerative diseases such as Creutzfeldt-Jakob dis
120 sorder of declining language associated with neurodegenerative diseases such as frontotemporal degene
122 relevant in the context of neurological and neurodegenerative diseases that involve changes in dopam
123 mer's disease is one of the most devastating neurodegenerative diseases without effective therapies.
124 de range of neurological diseases, including neurodegenerative diseases, after trauma, and after stro
125 une system are observed at various stages of neurodegenerative diseases, and may not only drive disea
126 rts that tau pathology is a feature of these neurodegenerative diseases, but also that tau pathology
128 Os are ideal candidates for the treatment of neurodegenerative diseases, given numerous advancements
129 yotrophic lateral sclerosis (ALS), two major neurodegenerative diseases, in single-nucleotide polymor
130 outpatient referral center for patients with neurodegenerative diseases, included 6 3 with typical am
131 gregates found in the brain of patients with neurodegenerative diseases, including Alzheimer's and Pa
134 ated with a number of pathologies, including neurodegenerative diseases, metabolic disorders, and can
136 ation of neurodevelopmental, psychiatric and neurodegenerative diseases, such as autism spectrum diso
137 preclinical onset of smell deficits in many neurodegenerative diseases, the answer to this question
139 zed role of mitochondrial quality control in neurodegenerative diseases, these studies illustrate, fo
140 hiles is associated with the pathogenesis of neurodegenerative diseases, to epigenetic alterations an
141 ential risk-increasing role across different neurodegenerative diseases, whereas the novel genetic as
192 igases and effectors that are mutated across neurodegenerative diseases; accordingly, these conjugate
193 utic target in breast cancer and age-related neurodegenerative diseases; however, CYP27A1 inhibition
194 T: Alzheimer's disease (AD) is a devastating neurodegenerative disorder and there are currently no ef
196 sociated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder caused by a limited expansion
198 Spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disorder caused by a polyglutamine-enc
200 Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused by mutations in NPC1 o
201 ltiple system atrophy (MSA) is a progressive neurodegenerative disorder characterised by a variable c
202 degeneration (AMD) is a progressive retinal neurodegenerative disorder characterized by extracellula
205 Alzheimer's disease (AD) is a prevalent neurodegenerative disorder triggered by the accumulation
206 ease (HD) is an autosomal dominant inherited neurodegenerative disorder, and no cure is available cur
207 of Huntington's disease (HD), a devastating neurodegenerative disorder, how proteasome activity is r
210 Genetic defects in DNA repair underlie other neurodegenerative disorders (eg, ataxia-telangiectasia),
212 r treating diverse human diseases, including neurodegenerative disorders and infectious diseases.
213 (alphaS) inclusions are found in a number of neurodegenerative disorders and is a hallmark feature of
216 are known to cause 10 late-onset progressive neurodegenerative disorders as the repeats expand beyond
217 hies (TSEs), are a group of rare progressive neurodegenerative disorders caused by an abnormally fold
218 d Parkinson disease, are rapidly progressive neurodegenerative disorders caused by misfolding followe
219 mporal dementia (FTD) encompasses a group of neurodegenerative disorders characterized by cognitive a
220 iseases are a group of progressive and fatal neurodegenerative disorders characterized by deposition
221 and Multiple System Atrophy are age-related neurodegenerative disorders characterized by progressive
222 lusions is linked to a number of devastating neurodegenerative disorders collectively known as tauopa
223 paraplegia, a highly heterogeneous group of neurodegenerative disorders defined by progressive neuro
224 wedish BioFINDER (Biomarkers for Identifying Neurodegenerative Disorders Early and Reliably) cohort (
225 ) and similar dementias are common incurable neurodegenerative disorders in the aging population.
226 TMEM106B are associated with several common neurodegenerative disorders including frontotemporal lob
229 ase that shares many similarities with other neurodegenerative disorders of the central nervous syste
231 of age-associated proteinopathies, including neurodegenerative disorders such as Alzheimer's and Park
233 l morphology contributes to the pathology of neurodegenerative disorders such as Alzheimer's disease
234 nding of the influence of innate immunity on neurodegenerative disorders such as Alzheimer's disease,
235 d insulin/IGF-1) have been reported in other neurodegenerative disorders such as Alzheimer's disease.
237 in a voxel, which is expected to increase in neurodegenerative disorders such as Parkinson's disease.
239 TSEs) or prion diseases are a group of fatal neurodegenerative disorders that include Kuru, Creutzfel
240 sease, dementia with Lewy bodies and genetic neurodegenerative disorders were alternative diagnoses i
241 ty of diseases, including diabetes, obesity, neurodegenerative disorders, aging, and cancer, making t
242 the death of neurons and oligodendrocytes in neurodegenerative disorders, and provide opportunities f
243 play a causative role in the pathogenesis of neurodegenerative disorders, critically modulating the e
244 -Hakola disease and associated with multiple neurodegenerative disorders, including Alzheimer's disea
246 brids is linked to various human cancers and neurodegenerative disorders, our study raises the possib
247 n aggregation is associated with age-related neurodegenerative disorders, such as Alzheimer's and pol
248 igomeric forms of amyloid proteins linked to neurodegenerative disorders, such as amyloid-beta (Abeta
250 PA) is a proposed treatment for RP and other neurodegenerative disorders, with a phase II trial for R
273 regation is thought to initiate a cascade of neurodegenerative events in Alzheimer's disease (AD).
274 eutic targets to prevent the onset, or delay neurodegenerative events in subjects exposed to this ris
275 ntly reduced prior to the development of the neurodegenerative hallmarks of SMA, implying a different
276 gical interest, particularly in the field of neurodegenerative, inflammatory, and infectious diseases
278 The Niemann-Pick type C1 (NPC1) disease is a neurodegenerative lysosomal storage disorder due to muta
279 MCOLN1 gene, which encodes TRPML1, cause the neurodegenerative lysosomal storage disorder mucolipidos
280 lete loss of PGRN expression and lead to the neurodegenerative lysosomal storage disorder neuronal ce
281 Parkinson's disease (PD) is the most common neurodegenerative movement disorder, affecting 1% of the
283 o died with dementia and were without severe neurodegenerative pathologies tended to have cerebrovasc
287 displaying functional hyperdopaminergia and neurodegenerative phenotype leading to premature death i
292 sensitive label-free real-time monitoring of neurodegenerative processes by impedance spectroscopy.
294 ngth, and a decreased expression on RhoA and neurodegenerative proteins [Abeta-peptide and p-Tau].
296 (DA) neurons in the substantia nigra (SN) to neurodegenerative stressors causes Parkinson's disease (
298 rain barrier, and impedes the progression of neurodegenerative symptoms in Drosophila models of Parki
299 ncoding betaIII spectrin are associated with neurodegenerative syndromes, spinocerebellar ataxia Type
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。